|
KLHL28 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.08721928629529E-14 |
| Normal-vs-Stage2 |
5.39840000479686E-08 |
| Normal-vs-Stage3 |
5.25024468345237E-13 |
| Normal-vs-Stage4 |
2.23721041692215E-12 |
| Stage1-vs-Stage2 |
8.692600E-01 |
| Stage1-vs-Stage3 |
1.390550E-01 |
| Stage1-vs-Stage4 |
1.701890E-02 |
| Stage2-vs-Stage3 |
4.166000E-01 |
| Stage2-vs-Stage4 |
8.450100E-02 |
| Stage3-vs-Stage4 |
2.687200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.005270E-04 |
| Normal-vs-Asian |
1.93579996476956E-09 |
| Caucasian-vs-AfricanAmerican |
3.249000E-01 |
| Caucasian-vs-Asian |
9.332600E-01 |
| AfricanAmerican-vs-Asian |
3.522200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.44169137633799E-15 |
| Normal-vs-Female |
1.62703184258817E-12 |
| Male-vs-Female |
2.841600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.16322532004187E-12 |
| Normal-vs-Age(41-60Yrs) |
2.18713935851156E-14 |
| Normal-vs-Age(61-80Yrs) |
1.92179605562615E-12 |
| Normal-vs-Age(81-100Yrs) |
1.364310E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.828600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.697370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.907200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.511200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.593400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.051000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.842250E-02 |
| Classical-VS-Follicular |
1.878840E-01 |
| Classical-VS-Other |
3.828000E-01 |
| Classical-VS-Normal |
1.67843516862831E-12 |
| Tall-VS-Follicular |
1.859210E-01 |
| Tall-VS-Other |
7.232600E-01 |
| Tall-VS-Normal |
5.38280531259261E-11 |
| Follicular-VS-Other |
6.915000E-01 |
| Follicular-VS-Normal |
3.80639963992735E-11 |
| Other-VS-Normal |
1.157340E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.14352971536391E-14 |
| Normal-vs-N1 |
1.27220012302587E-10 |
| N0-vs-N1 |
4.144400E-01 |
|
|
